Genmab A (GMAB) Gross Profit (2018 - 2026)

Genmab A (GMAB) posted Gross Profit of $831.0 million for Q1 2026, down 66.83% on a QoQ basis from $2.5 billion in Q3 2025, and up 23.48% year-over-year from $673.0 million in Q1 2025.

Genmab A (GMAB) Gross Profit (2018 - 2026) Analysis & Trends

Genmab A's Gross Profit history runs 6 years deep, the most recent figure standing at $831.0 million for Q1 2026.

  • Quarterly Gross Profit rose 23.48% year-over-year to $831.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 billion (up 18.62% YoY) and the FY2025 annual result came in at $3.5 billion, up 16.92% from the prior year.
  • Gross Profit was $831.0 million for Q1 2026 at Genmab A, down from $2.5 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $2.5 billion in Q3 2025 and bottomed at $576.0 million in Q1 2024.
  • A 3-year average of $1.4 billion and a median of $1.3 billion in 2024 frame the typical range for Gross Profit.
  • Annual changes were most pronounced in 2025 — Gross Profit climbed 16.13% — and 2026, when it advanced 23.48%.
  • Genmab A's Gross Profit stood at $2.1 billion in 2024, then advanced by 19.12% to $2.5 billion in 2025, then slumped by 66.83% to $831.0 million in 2026.
  • Business Quant data shows GMAB's Gross Profit at $831.0 million in Q1 2026, $2.5 billion in Q3 2025, and $1.5 billion in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Genmab A 1.89 Bn 366.92 Mn 831.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 831.00 Mn
Mar 31, 2026 831.00 Mn
Sep 30, 2025 2.51 Bn
Sep 30, 2025 2.51 Bn
Jun 30, 2025 1.54 Bn
Jun 30, 2025 1.54 Bn
Mar 31, 2025 673.00 Mn
Mar 31, 2025 673.00 Mn
Sep 30, 2024 2.10 Bn
Sep 30, 2024 2.10 Bn
Jun 30, 2024 1.33 Bn
Jun 30, 2024 1.33 Bn
Mar 31, 2024 576.00 Mn
Mar 31, 2024 576.00 Mn
Sep 30, 2020 1,715,910.00 Bn
Sep 30, 2020 1,715,910.00 Bn
Dec 31, 2019 1,032.78
Dec 31, 2019 1,032.78
Sep 30, 2019 -7,220.00
Sep 30, 2019 -7,220.00